by William Jester | Dec 9, 2022 | Community, News
Rutgers scientists have developed a new approach to stopping viral infections: a so-called live-attenuated, replication-defective DNA virus vaccine that uses a compound known as centanamycin to generate an altered virus for vaccine development. The method was tested...
by William Jester | Dec 8, 2022 | Community, News
On July 14, 2021, Bill Spadea, a popular talk-radio host on New Jersey station 101.5, shared with his listeners the news that the emergent Delta variant of Covid-19 wasn’t deadly. Two months later, Fox TV host Tucker Carlson broadcast the similarly encouraging news...
by William Jester | Dec 7, 2022 | Community, Covid, News
Technology that reliably kills airborne viruses inside buildings could prevent most cases of cold and flu and could have saved millions of lives during the COVID-19 pandemic, according to a Rutgers expert. Emanuel Goldman, professor of microbiology, biochemistry and...
by William Jester | Dec 7, 2022 | Community, Covid, News
Local vaccine trial sites are recruiting young children to test COVID-19 bivalent doses more than two months after the vaccines were authorized for use in adults, teens, and older children. Scientists will study the safety and efficacy of Pfizer-BioNTech’s bivalent...
by William Jester | Dec 6, 2022 | Community, News
A new Rutgers study suggests that sleep aids may do more than mitigate insomnia: They might also help reduce cravings for those struggling with alcohol and drug addiction. Why? It comes down to a hormone called orexin that stimulates drug and alcohol cravings, more...
